EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSMMSG00000007012
Gene Symbol: ITGA4
1 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSMMSG00000008546
Gene Symbol: ITGA5
1 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSMMSG00000009104
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSMMSG00000011743
Gene Symbol: ITGB1
1 Cross references
299 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSMMSG00000023217
Gene Symbol: ITGB3
1 Cross references
265 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSMMSG00000018600
Gene Symbol: ITGB5
1 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSMMSG00000023980
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSMMSG00000022688
Gene Symbol: ITGB7
1 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMMSG00000024452
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSMMSG00000005899
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSMMSG00000002022
Gene Symbol: IL5
1 Cross references
91 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSMMSG00000018507
Gene Symbol: IDH1
1 Cross references
232 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).